Drug recall · February 20, 2019
Cardizem CD recall
Why: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cardizem CD (diltiazem HCl) capsules, 180 mg, packaged in a) 30-count bottles (NDC 0187-0796-30); and b) 90-count bottles (NDC 0187-0796-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.
- Lots / codes
Lots: a) 18J018P, Exp 08/2020; b) 18J029P, Exp 08/2020
- Quantity
- 206 bottles
- Company
- Valeant Pharmaceuticals North America LLC, Bridgewater, NJ
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- January 30, 2019 · Voluntary: Firm initiated
- Classified
- February 14, 2019
- Reported
- February 20, 2019
- Ended
- July 8, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diltiazem
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.